| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |